Longitude Capital Partners III LLC 13D and 13G filings for Inozyme Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-11 4:08 pm Purchase | 2023-08-01 | 13D | Inozyme Pharma, Inc. INZY | Longitude Capital Partners III LLC | 5,841,045 9.900% | 1,666,666 (+39.93%) | Filing |
| 2022-04-28 4:50 pm Purchase | 2022-04-19 | 13D | Inozyme Pharma, Inc. INZY | Longitude Capital Partners III LLC | 4,174,379 10.400% | 1,355,000 (+48.06%) | Filing |
| 2020-08-07 5:21 pm Purchase | 2020-07-28 | 13D | Inozyme Pharma, Inc. INZY | Longitude Capital Partners III LLC | 2,819,379 12.100% | 2,819,379 (New Position) | Filing |